Cite
HARVARD Citation
Murphy, S. et al. (2021). Cost‐effectiveness implications of increasing the efficiency of the extended‐release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. Addiction. pp. 3444-3453. [Online].